Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATLong-Term Debt IssuancesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Nu-Med Plus (NUMD) Accumulated Depreciation & Amortization (2016 - 2022)

Nu-Med Plus' Accumulated Depreciation & Amortization history spans 11 years, with the latest figure at $9365.0 for Q4 2021.

  • On a quarterly basis, Accumulated Depreciation & Amortization fell 88.11% to $9365.0 in Q4 2021 year-over-year; TTM through Dec 2021 was $9365.0, a 88.11% decrease, with the full-year FY2021 number at $9365.0, down 88.11% from a year prior.
  • Accumulated Depreciation & Amortization hit $9365.0 in Q4 2021 for Nu-Med Plus, up from $6715.0 in the prior quarter.
  • Over the last five years, Accumulated Depreciation & Amortization for NUMD hit a ceiling of $82802.0 in Q2 2021 and a floor of $6715.0 in Q3 2021.
  • Historically, Accumulated Depreciation & Amortization has averaged $51060.3 across 5 years, with a median of $55464.5 in 2018.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: surged 51.08% in 2018 and later crashed 88.11% in 2021.
  • Tracing NUMD's Accumulated Depreciation & Amortization over 5 years: stood at $38834.0 in 2017, then surged by 37.96% to $53577.0 in 2018, then rose by 24.95% to $66943.0 in 2019, then grew by 17.62% to $78737.0 in 2020, then crashed by 88.11% to $9365.0 in 2021.
  • Business Quant data shows Accumulated Depreciation & Amortization for NUMD at $9365.0 in Q4 2021, $6715.0 in Q3 2021, and $82802.0 in Q2 2021.